Changes in atherosclerotic cardiovascular disease risk over time among people living with HIV.

Weisi ChenKathy PetoumenosAgus SomiaNatalie EdmistonRomanee ChaiwarithIan J WoolleyJeremy RossSanjay PujariDavid Charles Boettigernull null

Published in: The Journal of antimicrobial chemotherapy (2024)

These findings emphasize the growing burden of ASCVD risk among PLHIV and the need to develop interventions that are effective across a broad range of HIV sub-populations.

Keyphrases

cardiovascular disease
antiretroviral therapy
physical activity
human immunodeficiency virus
hiv infected
hepatitis c virus
type diabetes
coronary artery disease
cardiovascular events